Research Article
T Cell Response in Patients with Implanted Biological and Mechanical Prosthetic Heart Valves
Table 6
Impact of hypertonic disease on T cells populations in biological prosthesis recipients.
| | T cells populations | Healthy donors, | Hypertonic disease, | No hypertonic disease, | value |
| | CD3+% | 78.27 (73.07; 82.52) | 71.47 (62.71; 84.21) | 69.26 (65.58; 74.10) | 1–3 | | CD3+ abs. | 1419.31 (1126.25; 1735.91) | 1515.78 (1003.36; 1643.88) | 1204.92 (1004.40; 1327.53) | 1–3 | | CD3+CD8+% | 25.80 (20.64; 33.20) | 24.95 (23.07; 38.91) | 22.28 (18.07; 27.32) | n/s | | CD3+CD8+ abs. | 462.37 (349.70; 647.87) | 474.05 (360.40; 715.17) | 374.22 (259.48; 485.60) | n/s | | CM Tcyt%. | 11.50 (8.70; 16.38) | 6.41 (3.92; 7.50) | 5.99 (3.93; 7.94) | 1–3
1-2 | | CM Tcyt abs. | 51.69 (36.70; 74.30) | 30.38 (18.98; 46.34) | 21.11 (13.17; 29.11) | 1–3
1-2 | | EM Tcyt% | 31.82 (18.80; 43.55) | 33.21 (26.71; 42.60) | 27.09 (15.97; 35.61) | n/s | | EM Tcyt abs. | 122.56 (74.29; 196.04) | 162.12 (134.98; 201.94) | 115.56 (55.09; 130.77) | 2-3 | | TEMRA Tcyt% | 26.67 (19.58; 34.93) | 49.41 (43.46; 58.83) | 49.07 (40.68; 60.38) | 1–3
1-2 | | TEMRA Tcyt abs. | 104.32 (72.94; 188.42) | 206.02 (140.19; 443.37) | 173.57 (112.81; 284.02) | 1–3
1-2 | | N Tcyt% | 24.46 (16.51; 39.58) | 7.53 (3.45; 12.06) | 14.00 (10.98; 15.85) | 1–3
1-2
2-3 | | N Tcyt abs. | 98.47 (56.29; 199.74) | 33.37 (13.72; 43.46) | 46.67 (39.46; 64.74) | 1–3
1-2 | | CD3+CD4+% | 48.06 (41.04; 52.58) | 40.74 (32.23; 54.46) | 41.81 (36.60; 48.37) | n/s | | CD3+CD4+ abs. | 835.92 (624.17; 1096.10) | 817.20 (529.20; 1089.20) | 705.31 (580.50; 948.64) | n/s | | CM Th% | 44.67 (38.42; 49.32) | 46.91 (36.38; 48.95) | 38.68 (35.23; 44.05) | 1–3 | | CM Th abs. | 338.29 (269.64; 484.11) | 297.29 (221.39; 468.69) | 251.99 (227.73; 340.65) | 1–3 | | EM Th% | 24.02 (17.54; 30.71) | 33.21 (21.28; 36.49) | 24.28 (17.82; 28.74) | n/s | | EM Th abs. | 197.64 (150.63; 229.90) | 237.85 (155.53; 284.65) | 162.54 (121.90; 187.07) | 1–3
2-3 | | TEMRA Th% | 0.82 (0.37; 1.67) | 2.26 (0.94; 3.17) | 1.62 (0.90; 2.49) | 1–3 | | TEMRA Th abs. | 6.17 (3.11; 13.58) | 18.46 (4.25; 33.43) | 11.23 (6.24; 26.89) | 1–3 | | N Th% | 29.88 (19.81; 36.00) | 22.24 (16.52; 27.73) | 35.46 (27.88; 39.09) | 2-3 | | N Th abs. | 222.99 (145.88; 369.81) | 159.70 (87.42; 317.64) | 226.13 (140.38; 382.83) | n/s | | CD4/CD8 | 2.01 (1.34; 2.44) | 1.52 (1.16; 2.41) | 2.01 (1.47; 2.17) | n/s |
|
|
n/s: not significant.
|
